SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group (DJT) is trending as the Supreme Court's decision to strike down Trump's tariffs fuels widespread community discussion, with many debating the implications for the economy and anticipating his next moves amidst concerns over potential new trade measures.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

The SPY is trending amidst widespread market bewilderment as it rallied first when the Supreme Court struck down tariffs, only to continue climbing after former President Trump immediately announced new and additional global tariffs, creating contradictory bullish signals that the community is struggling to rationalize.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is seeing significant momentum as its cancer immunotherapy, Anktiva, secures new distribution partnerships to launch in Saudi Arabia and the broader MENA region, complementing recent European market authorization. The community is highly bullish, anticipating continued global expansion and discussing substantial short squeeze potential.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The market is actively grappling with the Supreme Court's tariff ruling and subsequent comments about imposing new global tariffs, fueling intense debate over whether this will spark a tech-led rally or lead to further volatility. Community sentiment is highly divided, with some anticipating bullish economic impacts while others express confusion over conflicting signals and broader geopolitical concerns.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending as a report citing a partner's struggles to secure financing for a key data center fuels a sharp community divide, with many dismissing it as "fake news" orchestrated to acquire cheap shares ahead of upcoming earnings, while others highlight concerns over the company's aggressive leverage.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending amidst expectations of its first adjusted operating profit, record-setting battery swap usage fueled by holiday travel, and reports of increased institutional investment. The community is actively discussing perceived stock price manipulation around key levels, with many anticipating a short squeeze as market dynamics evolve and recognizing the strategic value of NIO's battery swap infrastructure.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending with community discussion split between frustration over the stock's perplexing reaction to favorable tariff news and skepticism surrounding restructuring efforts, including layoffs at its Converse brand, despite recent insider buying.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending due to an exaggerated market reaction to Anthropic's new "Claude Code Security," sparking fears of AI disruption across the cybersecurity sector. However, many in the community believe this FUD-driven sell-off is an irrational misunderstanding of CrowdStrike's enterprise offerings and presents a significant buying opportunity.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian (TEAM) is undergoing a significant downturn, primarily fueled by widespread AI disruption fears affecting the enterprise software sector, exacerbated by concerns over customer relations and stock-based compensation. Community discussion is polarized, with some viewing the deep sell-off as an "absurdly cheap" buying opportunity, while others anticipate continued declines amid the "SaaSpocalypse."

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL (GRAL) is trending following a significant market downturn after its NHS-Galleri trial did not meet its primary endpoint, yet the company emphasized promising secondary data, including a four-fold higher cancer detection rate. Community debate rages between those who believe the setback signals a "complete failure" and others who contend the market's drastic reaction is an "overreaction" given positive secondary outcomes and robust cash runway.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Recommendation of "Hold" by Brokerages

Amicus Therapeutics, Inc. (NASDAQ:FOLD - Get Free Report) has been given a consensus recommendation of "Hold" by the fourteen brokerages that are covering the stock, Marketbeat.com reports. One...

Principal Financial Group Inc. Has $2.08 Million Stock Holdings in Amicus Therapeutics, Inc. $FOLD

Principal Financial Group Inc. boosted its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 1,229.5% during the third quarter, according to its most recent disclosure with the...

What to Expect From These Drug/Biotech Players This Earnings Season?

Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical, Insmed and Madrigal Pharmaceuticals as they prepare to report quarterly results this week.

Should Investors Buy, Sell or Hold Amicus Stock Ahead of Q4 Earnings?

FOLD heads into Q4 earnings with Galafold driving growth and Pombiliti + Opfolda aiding the top line. BioMarin is set to acquire the company for $4.8 billion.

New York State Common Retirement Fund Raises Stock Holdings in Amicus Therapeutics, Inc. $FOLD

New York State Common Retirement Fund raised its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 35.1% during the 3rd quarter, according to the company in its most recent Form...

Best Biotech Stocks To Watch Today - February 8th

Danaher, Vertex Pharmaceuticals, Medpace, Amicus Therapeutics, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of...

Promising Biotech Stocks To Watch Now - February 7th

Biotech Stocks To Add to Your Watchlist - February 6th

Danaher, Amicus Therapeutics, Vertex Pharmaceuticals, Moderna, argenex, Medpace, and ImmunityBio are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...

Amicus Therapeutics (NASDAQ:FOLD) Sees Large Volume Increase - Time to Buy?

Amicus Therapeutics (NASDAQ:FOLD) Sees Strong Trading Volume - Here's Why...

Amicus Therapeutics (NASDAQ:FOLD) Share Price Passes Above 200 Day Moving Average - Should You Sell?

Amicus Therapeutics (NASDAQ:FOLD) Share Price Passes Above 200 Day Moving Average - Here's What Happened...

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Current Price	$14.35
Prev Close	$14.35
Open	$14.35
Dividend Yield	0.00%
50-Day Moving Average	$13.59
Beta	0.83
Avg. Volume	9.82M
PE Ratio	-321.03

52-Week High	$14.38
52-Week Low	$5.51
Market Capitalization	$4.5B
EPS (Annual)	-$0.1843
Price to Book	19.21
Revenue Per Employee	$1.06M

FOLD
Amicus Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FOLD News

FOLDAmicus Therapeutics Inc